Contact Us
Tecvayli Global Market Report 2025
Global Tecvayli Market Report 2025
Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Tecvayli Global Market Report 2025

By Type (Monotherapy, Combination Therapy), By Indication (Relapsed Multiple Myeloma, Refractory Multiple Myeloma), By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies), By End User (Adult, Geriatric)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Tecvayli Market?

Tecvayli (generic name: teclistamab) is a prescription medication used to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer affecting plasma cells who have previously received at least four lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

The main types of in tecvayli are monotherapy and combination therapy. Monotherapy involves the treatment of a disease or condition using a single drug or therapy, often chosen when it is sufficient to manage or cure the condition. It is used for indications in relapsed multiple myeloma and refractory multiple myeloma. It is distributed through various channels such as hospital pharmacies, specialty clinics, and online pharmacies. catering to various end users such as adults and geriatrics.

Tecvayli Market Size and growth rate 2025 to 2029: Graph

What Is The Tecvayli Market Size 2025 And Growth Rate?

The tecvayli market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in the incidence of multiple myeloma, growth in the aging population, increased demand for targeted therapies, increased healthcare expenditure, and growing awareness and diagnosis rates.

What Is The Tecvayli Market Growth Forecast?

The tecvayli market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to expanding global healthcare access, rising healthcare awareness, rising adoption of BCMA-targeted treatments, increasing adoption of personalized medicine, and rising demand for targeted cancer treatments. Major trends in the forecast period include advancements in biomarker testing for personalized treatment, advancements in gene therapies, integration of Tecvayli in combination therapies, improvement in diagnostic technologies, and advancements in immuno-oncology.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Tecvayli Market Segmented?

The tecvayli market covered in this report is segmented –

1) By Type: Monotherapy; Combination Therapy

2) By Indication: Relapsed Multiple Myeloma; Refractory Multiple Myeloma

3) By Distribution Channel: Hospital Pharmacies; Specialty Clinics; Online Pharmacies

4) By End User: Adult; Geriatric

What Is Driving The Tecvayli Market? Increasing Multiple Myeloma Cases To Propel The Market Growth

The increasing prevalence of multiple myeloma is expected to propel the growth of the tecvayli market going forward. Multiple myeloma is a cancer of plasma cells that remains challenging to treat, particularly in relapsed or refractory stages. The rise in multiple myeloma is attributed to factors such as aging populations and advancements in diagnostic capabilities, leading to a growing demand for effective and targeted therapies. Tecvayli helps the prevalence of multiple myeloma by enhancing T-cell-mediated killing of myeloma cells, reducing tumors, and improving patient outcomes in relapsed or refractory cases. For instance, in August 2024, according to the American Cancer Society, a US-based professional organization company, in 2024, approximately 35,780 new cases of multiple myeloma are projected to be diagnosed in the United States, with a breakdown of 19,520 cases in men and 16,260 cases in women. Additionally, it is estimated that the disease will result in 12,540 fatalities, including 7,020 men and 5,520 women. Therefore, the increasing prevalence of multiple myeloma is driving the growth of the tecvayli market.

What Is Driving The Tecvayli Market? Increased Investment In Cancer Research To Accelerate The Market Growth

The increasing investment in cancer research is expected to propel the growth of the tecvayli market going forward. Cancer research refers to scientific studies focused on understanding cancer's causes, mechanisms, diagnosis, treatment, and prevention to develop effective therapies and improve patient outcomes. The increased investment in cancer research can be attributed to rising cancer incidence, growing public awareness, the potential for groundbreaking treatments, and the need for more effective personalized therapies. Research investment often results in refined dosing schedules, reduced side effects, and optimized treatment protocols. These improvements enhance Tecvayli's appeal to healthcare providers and patients. For instance, in 2023, according to the American Society for Radiation Oncology (ASTRO), a US-based organization dedicated to advancing the field of radiation oncology, the National Cancer Institute (NCI) allocated approximately $7.3 billion for cancer research, marking a 5.9% increase compared to the previous year. A significant portion of this budget was dedicated to research project grants and clinical trials, including an additional $407.6 million directed explicitly toward cancer research initiatives. Therefore, increased investment in cancer research is driving the growth of the tecvayli market.

Who Are The Major Players In The Global Tecvayli Market?

Major companies operating in the tecvayli market are Johnson And Johnson

What Are The Key Trends Of The Global Tecvayli Market? Janssen's TECVAYLI Gains FDA Approval For Treating Relapsed Multiple Myeloma With Advanced Monoclonal Antibody Therapy

The key trend in the tecvayli market is developing innovative therapies such as monoclonal antibody therapies to improve treatment efficacy and patient outcomes in hematologic cancers. Monoclonal antibody therapies are lab-engineered antibodies designed to target specific proteins on cells or pathogens, enhancing the immune system's ability to fight diseases such as cancer. For instance, in October 2022, Johnson and Johnson Services Inc., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval for TECVAYLI (teclistamab-cqyv) as a treatment for adult patients with relapsed or refractory multiple myeloma. This approval was granted for patients who had previously undergone four or more lines of therapy, including a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 monoclonal antibody. TECVAYLI is a first-in-class bispecific T-cell engager antibody designed to activate the immune system by targeting the CD3 receptor on T-cells and the B-cell maturation antigen (BCMA) on myeloma cells.

Need data on a specific region in this market?

Regional Analysis For The Global Tecvayli Market

North America was the largest region in the tecvayli market in 2024. The regions covered in the tecvayli market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tecvayli market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tecvayli Market?

The tecvayli market consists of sales of associated diagnostics, supportive care therapies, injection devices, biosimilars, and pre-filled syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tecvayli Industry?

The tecvayli market research report is one of a series of new reports from The Business Research Company that provides tecvayli market statistics, including the tecvayli industry global market size, regional shares, competitors with the tecvayli market share, detailed tecvayli market segments, market trends, and opportunities, and any further data you may need to thrive in the tecvayli industry. This tecvayli market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Tecvayli Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The tecvayli market covered in this report is segmented –
1) By Type: Monotherapy; Combination Therapy
2) By Indication: Relapsed Multiple Myeloma; Refractory Multiple Myeloma
3) By Distribution Channel: Hospital Pharmacies; Specialty Clinics; Online Pharmacies
4) By End User: Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson And Johnson
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Tecvayli Market Characteristics

3. Tecvayli Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Tecvayli Market Trends And Strategies

5. Tecvayli Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Tecvayli Growth Analysis And Strategic Analysis Framework

6.1. Global Tecvayli PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Tecvayli Market Growth Rate Analysis

6.4. Global Tecvayli Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Tecvayli Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Tecvayli Total Addressable Market (TAM)

7. Global Tecvayli Pricing Analysis & Forecasts

8. Tecvayli Market Segmentation

8.1. Global Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Monotherapy

Combination Therapy

8.2. Global Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Relapsed Multiple Myeloma

Refractory Multiple Myeloma

8.3. Global Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Specialty Clinics

Online Pharmacies

8.4. Global Tecvayli Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult

Geriatric

9. Global Tecvayli Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Tecvayli Market Regional And Country Analysis

10.1. Global Tecvayli Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Tecvayli Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Tecvayli Market

11.1. Asia-Pacific Tecvayli Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Tecvayli Market

12.1. China Tecvayli Market Overview

12.2. China Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Tecvayli Market

13.1. India Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Tecvayli Market

14.1. Japan Tecvayli Market Overview

14.2. Japan Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Tecvayli Market

15.1. Australia Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Tecvayli Market

16.1. South Korea Tecvayli Market Overview

16.2. South Korea Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Tecvayli Market

17.1. Western Europe Tecvayli Market Overview

17.2. Western Europe Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Tecvayli Market

18.1. UK Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Tecvayli Market

19.1. Germany Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Tecvayli Market

20.1. France Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Tecvayli Market

21.1. Eastern Europe Tecvayli Market Overview

21.2. Eastern Europe Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Tecvayli Market

22.1. North America Tecvayli Market Overview

22.2. North America Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Tecvayli Market

23.1. USA Tecvayli Market Overview

23.2. USA Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Tecvayli Market

24.1. Canada Tecvayli Market Overview

24.2. Canada Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Tecvayli Market

25.1. South America Tecvayli Market Overview

25.2. South America Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Tecvayli Market

26.1. Middle East Tecvayli Market Overview

26.2. Middle East Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Tecvayli Market

27.1. Africa Tecvayli Market Overview

27.2. Africa Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Tecvayli Market Competitive Landscape And Company Profiles

28.1. Tecvayli Market Competitive Landscape

28.2. Tecvayli Market Company Profiles

28.2.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

29. Global Tecvayli Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Tecvayli Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Tecvayli Market

32. Recent Developments In The Tecvayli Market

33. Tecvayli Market High Potential Countries, Segments and Strategies

33.1 Tecvayli Market In 2029 - Countries Offering Most New Opportunities

33.2 Tecvayli Market In 2029 - Segments Offering Most New Opportunities

33.3 Tecvayli Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Tecvayli Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Tecvayli Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Tecvayli Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Johnson And Johnson Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Tecvayli Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Tecvayli Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Tecvayli Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Tecvayli Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Tecvayli Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Tecvayli Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Johnson And Johnson Financial Performance

Frequently Asked Questions

Tecvayli (generic name: teclistamab) is a prescription medication used to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer affecting plasma cells who have previously received at least four lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. For further insights on the Tecvayli market, request a sample here

The Tecvayli market major growth driver - Increasing Multiple Myeloma Cases To Propel The Market Growth. For further insights on the Tecvayli market, request a sample here

The Tecvayli market size has grown strongly in recent years. The tecvayli market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rise in the incidence of multiple myeloma, growth in the aging population, increased demand for targeted therapies, increased healthcare expenditure, and growing awareness and diagnosis rates. The tecvayli market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to expanding global healthcare access, rising healthcare awareness, rising adoption of BCMA-targeted treatments, increasing adoption of personalized medicine, and rising demand for targeted cancer treatments. Major trends in the forecast period include advancements in biomarker testing for personalized treatment, advancements in gene therapies, integration of Tecvayli in combination therapies, improvement in diagnostic technologies, and advancements in immuno-oncology. For further insights on the Tecvayli market, request a sample here

The tecvayli market covered in this report is segmented –
1) By Type: Monotherapy; Combination Therapy
2) By Indication: Relapsed Multiple Myeloma; Refractory Multiple Myeloma
3) By Distribution Channel: Hospital Pharmacies; Specialty Clinics; Online Pharmacies
4) By End User: Adult; Geriatric For further insights on the Tecvayli market,
request a sample here

North America was the largest region in the tecvayli market in 2024. The regions covered in the tecvayli market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tecvayli market, request a sample here.

Major companies operating in the tecvayli market are Johnson And Johnson . For further insights on the Tecvayli market, request a sample here.

Major trends in the Tecvayli market include Janssen's TECVAYLI Gains FDA Approval For Treating Relapsed Multiple Myeloma With Advanced Monoclonal Antibody Therapy. For further insights on the Tecvayli market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon